NCT01258205 Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects Status COMPLETED Phase PHASE1
NCT01244386 Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT01235689 Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01235325 The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients Status COMPLETED Phase PHASE4
NCT01233960 Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01224171 Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01215890 Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease Status COMPLETED Phase PHASE4
NCT01203631 Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT01199302 Long-term Safety Study of Brodalumab in Adults With Crohn's Disease Status TERMINATED Phase PHASE2
NCT01190839 A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence Status TERMINATED Phase PHASE3
NCT01190410 Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol Status COMPLETED Phase PHASE2
NCT01183403 CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease Status COMPLETED Phase N/A
NCT01181765 The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy Status COMPLETED Phase PHASE4
NCT01155362 A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT01150890 Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT01144962 Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy Status UNKNOWN Phase NA